Is VISP an independent administrator? Here's what some documents say
This was the reason PHAC outsourced the administration of VISP in the first place: to avoid a potential conflict of interest between its role as promoter and approver of COVID-19 vaccines and the role as administrator of another program that offers financial support to those damaged by the shots.
Despite the assertion that VISP is independent, a PHAC communications strategy for the Vaccine Injury Support Program reveals that PHAC and Oxaro (formerly RCGT Consulting) regularly consult each other before responding to any question about the program, or to questions about VISP claimant cases that are asked by journalists or members of Parliament.
View image in full screen
An excerpt of a PHAC email obtained under the Access to Information Act. Global News
A second document shows that PHAC and Oxaro agreed to co-develop what their VISP funding agreement described as 'a joint litigation-management plan.'
Story continues below advertisement
The plan requires them to work together 'for the purpose of mitigating risk of litigation' that could be launched against the agency or company, the document says.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
A copy of the PHAC funding agreement was obtained under the Access to Information Act.
View image in full screen
Two pages from the 2021 government funding agreement between Public Health Agency of Canada and Oxaro (then called Raymond Chabot Grant Thornton Consulting) shows they agreed to develop a litigation management plan. Global News
Global News suggested to Oxaro that such arrangements suggest the consulting company is not an entirely independent administrator.
Oxaro's written response? 'This question should be addressed to PHAC.'
When Global News asked PHAC, the agency's repeated response was: 'VISP is being administered and delivered independently by Oxaro.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
4 hours ago
Regular cannabis use can cause a serious vomiting syndrome. Should people be warned?
When Brittany Ramsey started experiencing awful stomach episodes she thought it must've been side effects of the medication she was taking to manage her diabetes. But after a particularly gruelling episode where she just could not stop vomiting — not being keep down even small sips of water — that landed her in hospital, Ramsey knew something felt different about what she was experiencing. From then, the episodes got worse and worse, and closer together, said Ramsey, a 35-year-old operations trainer at a financial firm in Cincinnati, Ohio. From 2021 to 2024 … three years, I was hospitalized 29 times. Five ambulance trips – one actually had to pick me up on the side of the road because I couldn't make it to the hospital. After years of undergoing, at times, invasive testing procedures to rule out Crohn's disease, gastroparesis and diverticulitis, a doctor told Ramsey about cannabis hyperemesis syndrome (CHS). ER visits related to CHS have increased in Ontario in recent years, according to a 2022 study. (Frank Gunn/The Canadian Press) Photo: (Frank Gunn/The Canadian Press) In recent years some emergency rooms have been seeing an uptick in visits due to cyclic episodes of uncontrollable vomiting in cannabis users, often characterized by experiencing temporary relief with hot showers and baths. Since it was first identified in medical literature in 2004, CHS cases have increased, possibly because of greater cannabis access or higher THC potency of products. Public health researchers suggest more awareness of CHS within the health-care system is needed for cannabis users to get the information and support they need. More CHS cases in the ER CHS is characterized by severe and persistent vomiting and is usually seen in people who have been using cannabis several times a week for multiple years, said Jamie Seabrook, a professor at the Department of Epidemiology and Biostatistics at Western University in London, Ont. Ramsey said she'd been smoking at least once a day for over 10 years since she was 18 when she first started experiencing CHS symptoms in 2017. A 2022 study (new window) by researchers at the Ottawa Hospital Research Institute looked at the rate of emergency department visits for CHS after recreational cannabis was legalized and commercialized in Ontario, looking at nearly 13,000 CHS-related hospitalizations in Ontario from 8,140 individuals between 2014 and 2021. The study, published in the Journal of the American Medical association (JAMA), found that emergency department visits related to CHS had increased by 13-fold over a period of nearly eight years (new window) . The study doesn't show what caused the change, but the authors noted that the biggest increase in visits came not after legalization in 2018 but after Ontario allowed expansion of retail stores in 2020, which coincided with the COVID-19 pandemic. Though we don't have numbers how many people have been diagnosed or hospitalized with CHS, online communities are filled with people looking for support. Ramsey is part of one of them — a CHS Facebook group described as a safe place to recover and learn with 3,000 members. The largest CHS Facebook group has 31,000 members. On Reddit, the group r/CHSinfo has 20,000 members, with discussions ranging from tips on how to manage episodes and personal anecdotes about repeated hospitalizations. Seabrook, who co-authored a recent review of existing research on CHS in youth, said there's been an "explosion" (new window) of people showing up in some North American emergency rooms with CHS within the last seven to eight years. The Ottawa Hospital Research Institute study showed that other cannabis-related emergency room visits, including for intoxication and dependence, saw a substantial increase starting in early 2020 as well. Surge in THC potency since the 1980s Seabrook said a likely reason for increased rates of CHS is the high THC potency of cannabis products today. THC is the compound in cannabis that is responsible for the sensation of a high most people experience when consuming it. When its potency increases, so do its harmful effects. Different strains of the plant will have different concentrations of active compounds, measured by percentage of total weight or volume. On average, THC content is much higher today than it used to be. The potency of THC was only about three per cent in the 1980s and today, according to Health Canada, the average is 15 per cent with some strains as high as 30 per cent, Seabrook said, citing Health Canada numbers (new window) for "fresh or dried herb material." "So we're talking a 400 per cent or higher increase in the potency. For chemically concentrated extracts, such as hash oil, shatter, budder and wax, the typical potency can be up to 90 per cent, according to Health Canada data (new window) . The potency, I think, is what's causing the illnesses to become more and more prevalent, because they're smoking a lot more potent stuff, Ramsey said. And that's the same with me. When I first started smoking, it was my brother's homegrown stuff, versus getting it from friends and dispensaries out in California, where it does get stronger and stronger. I feel like maybe before just making marijuana available to the masses, maybe some of these things should have been looked into. You know, too much of anything might be bad, said Ramsey. Lawsuit against Aurora Cannabis cites CHS A lawsuit was recently brought against Canadian cannabis production company Aurora Cannabis for alleged negligence of failing to warn consumers about the potential risk for developing CHS from the regular use of its products. The lawsuit was certified by the Ontario Superior Court of Justice last month, meaning it can proceed as a class action. Margaret Waddell, the lawyer prosecuting the case, said she hopes that if the lawsuit is successful, it could have an industry-wide effect on including CHS in their product labelling. Ideally, Health Canada will require them at some point, Waddell said. Health Canada does require cannabis manufacturers to warn customers about specified risks (new window) — including psychotic symptoms, addiction and dependence — but Waddell said there aren't currently any requirements to specifically include CHS in those warnings. Aurora Cannabis declined to comment on the lawsuit, writing in an emailed statement: It is the company's practice not to comment on legal matters beyond information that is made available to the public. Information that [CHS] exists is very important, Seabrook said. In schools, in health-care settings – whether that's neurologists, psychiatrists, [emergency room] doctors – and public health campaigns, so people can make a better informed decision about their cannabis use. Shaki Sutharsan (new window) · CBC News
Global News
13 hours ago
- Global News
Is VISP an independent administrator? Here's what some documents say
The Public Health Agency of Canada publicly identifies Oxaro as VISP's 'independent 3rd party administrator' to highlight the arm's-length relationship between government and contractor. This was the reason PHAC outsourced the administration of VISP in the first place: to avoid a potential conflict of interest between its role as promoter and approver of COVID-19 vaccines and the role as administrator of another program that offers financial support to those damaged by the shots. Despite the assertion that VISP is independent, a PHAC communications strategy for the Vaccine Injury Support Program reveals that PHAC and Oxaro (formerly RCGT Consulting) regularly consult each other before responding to any question about the program, or to questions about VISP claimant cases that are asked by journalists or members of Parliament. View image in full screen An excerpt of a PHAC email obtained under the Access to Information Act. Global News A second document shows that PHAC and Oxaro agreed to co-develop what their VISP funding agreement described as 'a joint litigation-management plan.' Story continues below advertisement The plan requires them to work together 'for the purpose of mitigating risk of litigation' that could be launched against the agency or company, the document says. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy A copy of the PHAC funding agreement was obtained under the Access to Information Act. View image in full screen Two pages from the 2021 government funding agreement between Public Health Agency of Canada and Oxaro (then called Raymond Chabot Grant Thornton Consulting) shows they agreed to develop a litigation management plan. Global News Global News suggested to Oxaro that such arrangements suggest the consulting company is not an entirely independent administrator. Oxaro's written response? 'This question should be addressed to PHAC.' When Global News asked PHAC, the agency's repeated response was: 'VISP is being administered and delivered independently by Oxaro.'
Global News
13 hours ago
- Global News
‘Nothing Was Ready': Inside Canada's Vaccine Injury Support Program
A $50-million program the federal government created to help Canadians seriously injured by COVID-19 vaccines is in disarray, current and former staffers say. The Vaccine Injury Support Program (VISP), created during the pandemic, was designed to compensate people who have been seriously and permanently injured by any Health Canada-authorized vaccine administered in Canada on or after Dec. 8, 2020. The Public Health Agency of Canada subsequently selected a consulting firm, Oxaro Inc., to administer the program. The Ottawa-based company vowed it had the 'people, processes, and tools' to run the initiative with 'industry best practices.' However, a five-month-long Global News investigation, involving more than 30 interviews with current and former Oxaro employees, injured claimants and their attorneys, has uncovered allegations that the company was unequipped to deliver fully on the program's mission, questions about why the Public Health Agency of Canada (PHAC) chose this company over others, and internal documents that suggest poor planning from the start. Global News also heard descriptions of a workplace that lacked the gravitas of a program meant to assist the seriously injured and chronically ill: drinking in the office, ping pong, slushies and Netflix streaming at desks. The overall result: many claimants feel they have not received the 'timely and fair' access to support that the government promised. View image in full screen People wait in line at a COVID-19 vaccination site in Montreal in January 2022. Graham Hughes / Canadian Press When the pandemic struck in 2020, Canada was caught flat-footed. Advertisement It was the only G7 country without a vaccine injury support program. Millions of Canadians lined up for the shots, which helped reduce emergency room admissions and curtail the impact of the pandemic. The government reassured the public that they'd be safe, but it acknowledged that in rare cases, people could experience serious side effects. There have been 11,702 reports of serious adverse events following a COVID-19 vaccination, according to Health Canada. That's equal to 0.011 per cent of the 105,015,456 doses administered as of December 2023. Reactions included Guillain-Barré Syndrome, myocarditis, cardiac arrest and Bell's Palsy. For those unfortunate few, then-prime minister Justin Trudeau pledged that VISP would look after them. 'We want to make sure that Canadians have fair access to support,' he said in December 2020. Two months later, PHAC invited companies to submit proposals for administering VISP, saying the agency lacked the staff and expertise to operate the program itself, according to a draft 2023 report on VISP by Health Canada and PHAC. The government viewed the outsourcing decision as 'the best option.' That way, it could avoid a conflict of interest that would arise from serving as both the approver of the vaccines and the one that compensated people for the harms vaccines caused, the documents explained. Four entities responded to the PHAC request and had roughly three weeks to apply. Among them was Oxaro (then called Raymond Chabot Grant Thornton Consulting Inc.), a firm that vowed to employ 'experienced dedicated case managers to support a claimant throughout the application process.' It won the contract. The minister of health pushed Oxaro to launch three months ahead of schedule. But when the program did, in June 2021, some former staffers say the company wasn't ready. View image in full screen Global News Oxaro and the Public Health Agency of Canada declined to be interviewed for this story. In a statement to Global News, Oxaro wrote, 'Our process ensures that all cases are treated fairly and with the same care, respect, and due diligence.' 'Building the program as they went' Seven former workers told Global News that the staff VISP hired to run the day-to-day operations had little, if any, experience in public health, insurance or claims management. Many employees were straight out of high school or college, or had previous jobs in retail, bartending and data entry, according to former workers and LinkedIn résumés. There was a revolving door of staff, according to several former employees. A half dozen members of the team that helped prepare the VISP bid were gone within six months, according to three sources familiar with the matter. Claims managers with more experience were eventually hired, but at least three quit, according to their colleagues. Among the employee frustrations, there was also no clear roadmap for managing a claim. Five current and former workers told Global News that policies and procedures were incomplete. Others bemoaned a lack of training. 'They (VISP) had no idea what they were doing,' one former worker said. 'Nothing was ready. We were still being designed two years after the contract was awarded.' 'They were building the program as they went,' another said. The Public Health Agency of Canada did write a policy framework for VISP, but it was up to Oxaro to design and implement it, according to PHAC documents. It wasn't properly fleshed out, former workers said. Advertisement 'I asked for the policy language we would use to decide cases,' one said. 'There was none.' As a result, another worker said they relied on 'word of mouth' to figure out how to handle claims. And to some injured claimants, that lack of guidance was obvious. Monroe Orleans, a realtor from Hamilton, says his VISP case manager asked him to contact his cardiologist to obtain a letter about his personal tax status. View image in full screen Monroe Orleans seen before and during his hospitalization for a vaccine injury to his heart. He says a VISP case manager asked him to contact his cardiologist to obtain a letter about his personal tax status. Courtesy Monroe Orleans 'Why?!' he exclaimed, mystified, questioning how a heart doctor would know anything about tax filings. VISP eventually approved Orleans' case for heart damage he suffered after getting the COVID-19 vaccine. He has a second claim for kidney failure still pending. Kimberly Macdougall, whose husband died of myopericarditis post-COVID-19 vaccine, was also left dumbfounded. At the height of her grief, VISP asked her to retrieve physiotherapy records from three years earlier, when her husband broke his hand playing ultimate frisbee. 'What does that have to do with anything?' she said. VISP also approved her case. View image in full screen Kimberly MacDougall questions why VISP required physiotherapy records from her late-husband, for a hand injury which occurred three years before his death. Patrick Capati / Global News Claims of drinking, ping pong, Netflix Inside VISP's downtown Ottawa office, the work culture included Friday afternoon drinks, ping pong games (often so loud they affected productivity), slushie machines, streaming videos on phones and 'a lot' of chitchat, former workers described. 'I felt like I was there to kind of hang out and socialize,' one said. 'It was kind of like school in a way.' Concerned about appearances, a top Oxaro executive sent an email in advance of an office visit from the Public Health Agency of Canada, instructing workers not to watch videos during the office drop-in. Though two workers confirmed the existence of the email, Global News was unable to obtain a copy. In the last year, some workers said, drinking on Fridays has ceased and the company has tried to curb video streaming in the office. Oxaro would not respond to questions about its workplace culture, nor would it comment on statements by former workers. Former workers say the casual environment inside VISP contributed to the company missing its targets. Claims piled up. One worker confessed that the amount of work they completed was 'well below' what was expected. Lost in the rising number of claims were the injured, the worker added. 'I don't think anyone actually understood the severity or the relevance of the program that was being contracted to the firm,' they said. 'I think they (injured claimants) were merely names on paper and nothing more than that.' View image in full screen People who say they have been hurt by vaccines must complete an application form before their claim can be evaluated. PHAC Those injured claimants said the treatment from VISP workers 'lacked humanity.' Advertisement One injured woman, whose case was eventually approved, said she was brought to tears when her claims manager shouted at her and swore, 'You're just after free money.' That same VISP case manager allegedly told a second injured person: 'You didn't have to get the vaccine.' He was later fired, according to former workers. Several workers said that despite the team's inexperience and limited resources, they still tried their hardest to provide support payments to those in need. View image in full screen VISP has approved 219 cases. More than 3,000 people have applied. 'I did everything I could for that program. I couldn't do any more,' one former worker said. A second former staffer said that in recent months, there were signs of improvement, but that the system was still as slow as 'molasses.' 'It's frustrating,' he said. 'I can't help these (injured) individuals out.' View image in full screen The Public Health Agency of Canada is based in Ottawa. Rob Kazemzadeh / Global News Global News sent Oxaro a 15-page list of questions, including detailed allegations from former workers and claimants. Oxaro would not comment on those specifics, stating instead it is working with PHAC and 'continues to adapt its approach based on actual number of applications and appeals received.' Read Oxaro's response to Global News. PHAC told Global News it 'takes the concerns raised by VISP claimants and beneficiaries seriously' and is 'actively reviewing the VISP experience to date,' including an examination of best practices from other countries, to ensure its 'future program will effectively meet the needs of Canadians.' The government's five-year deal with Oxaro is up for renewal in mid-2026. View image in full screen Of the $50.6 million the government of Canada has paid to Oxaro, a third of that amount, $16.9 million, has reached the injured. Oxaro has spent the rest on administrative and program costs, PHAC data shows. Oxaro said its monthly invoices to the government 'reflect actual costs' that are 'reviewed and approved by PHAC.' Health Canada Minister Marjorie Michel, via a spokesperson, sent an unsolicited email to Global News prior to publication, saying: 'These allegations are completely unacceptable… I've asked PHAC to find a solution that ensures a responsible use of funds and that people receive the support they need. All options are on the table.' Why a consulting firm? The question many injured claimants and former workers have raised over the course of this investigation: how did an accounting and advisory firm land a contract managing health claims? In its 155-page submission, Raymond Chabot Grant Thornton Consulting Inc. (now Oxaro) cited two examples of its experience in health claim adjudication. Advertisement One was designing and operating the Memorial Grant Program for First Responders, a smaller federal program that pays out a one-time, lump sum to beneficiaries of emergency workers who died as a direct result of their duties. The other was acting as liquidator of Union of Canada Life Insurance after it became insolvent in 2012, processing outstanding accident, life and medical claims, and transferring policies to other insurers until 2015. Three other contenders There were three other bidders for the VISP contract, and all had health claims adjudication experience: Green Shield Canada, Crawford & Company (Canada) Inc. and ClaimsPro LP. Global News obtained a redacted copy of Green Shield's proposal, which highlighted its track record as Canada's 'fourth-largest health and dental benefits provider,' boasting over 60 years of experience. 'We are ready to begin intaking claims within 45 days,' the GSC bid stated, adding it had a proven track record of timely claim payments, with 99.9 per cent accuracy over each of the last four years. View image in full screen Green Shield Canada submitted a detailed proposal to administer VISP back in 2021, highlighting its decades of experience and status as a non-profit company. In March 2021, a six-person committee 'unanimously' selected RCGT, PHAC said. Although the Public Health Agency refused to explain why or how that decision was reached, it did reveal that RCGT (Oxaro) was neither the highest nor lowest bidder. The unsuccessful bidders would not answer questions from Global News. A flawed forecast As VISP enters its fifth year, roughly 1,700 applicants are still waiting for their cases to be reviewed and decided, according to VISP data. Part of the reason: the initial forecast for the volume of claims VISP would receive was wildly inaccurate, and the system wasn't prepared for the influx. In February 2021, PHAC initially estimated VISP would get 40 claims per year, with the possibility of higher-than-average numbers in the first three years. View image in full screen That number was bumped up to 400 'valid' claims annually, according to the contract between RCGT and PHAC signed four months later. It received that amount in the first five months alone, according to VISP data. VISP has received 3,073 claims to date. That unforeseen volume hampered the program's effectiveness almost from the start. Instead of living up to its bid promise of a call centre that would respond to emails within one hour and contact from an applicant within one day '90% of the time,' applicants have recently received emails stating, 'due to an unexpectedly high volume of claims' VISP will 'aim to contact claimants quarterly.' View image in full screen VISP has sent several claimants an automatic email response, saying they will aim to contact them 'quarterly.' In its written response, Oxaro said, 'VISP is a new and demand-based program with an unknown and fluctuating number of applications and appeals.' It continued, 'The volume of claims received does have a direct impact on processing timelines,' as does their 'nature and complexity.' Advertisement PHAC and Oxaro workers have stated the average claim takes 12-18 months to process. Some applicants who spoke with Global News have been waiting three years for their claim to be decided.
